Overview

A Pilot Study to Assess the Safety and Efficacy of Oral PTH (1-34) in the Treatment of Hypoparathyroidism

Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
This is an observational, international, open label, pilot study to evaluate the safety, tolerability and efficacy of an oral PTH (1-34) preparation produced by Entera Bio in adult hypoparathyroid volunteers.
Phase:
Phase 2
Details
Lead Sponsor:
Entera Bio Ltd.
Treatments:
Hormones
Parathyroid Hormone
Teriparatide